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Osteoclasts are bone-resorbing cells that play a pivotal role in bone remodeling. Osteoclasts 
form large multinuclear giant cells by fusion of mononuclear osteoclasts. How cell fusion is 
mediated, however, is unclear. We identify the dendritic cell–specific transmembrane 
protein (DC-STAMP), a putative seven-transmembrane protein, by a DNA subtraction screen 
between multinuclear osteoclasts and mononuclear macrophages. DC-STAMP is highly 
expressed in osteoclasts but not in macrophages. DC-STAMP–deficient mice were generated, 
and osteoclast cell fusion was completely abrogated in homozygotes despite normal 
expression of osteoclast markers and cytoskeletal structure. As osteoclast multinucleation 
was restored by retroviral introduction of 
 
DC-STAMP
 
, loss of cell fusion was directly 
attributable to a lack of DC-STAMP. Defects in osteoclast multinucleation reduce bone-
resorbing activity, leading to osteopetrosis. Similar to osteoclasts, foreign body giant cell 
formation by macrophage cell fusion was also completely abrogated in DC-STAMP–deficient 
mice. We have thus identified an essential regulator of osteoclast and macrophage cell 
fusion, DC-STAMP, and an essential role of osteoclast multinucleation in bone homeostasis.
 
Osteoclasts are unique bone-resorbing cells,
and mice carrying a mutant gene responsible
for osteoclast formation exhibit the osteope-
trotic phenotype (1, 2). Foreign body giant
cells (FBGCs), which are monocyte/macrophage
lineage cells, are generated in response to foreign
bodies at the site of implantation (3). Both osteo-
clasts  and FBGCs form multinuclear cells by
fusion of monocyte/macrophage lineage cells.
Mononuclear macrophages recognize each
other and fuse to form multinuclear giant cells;
thus, cell surface molecules are considered to
be fusion-mediating molecules in osteoclasts
and macrophages. E-Cadherin and macro-
phage fusion receptor have been identified as
fusion molecules for osteoclasts and macrophages
through the use of neutralizing antibodies (4,
5). CD44, CD9, and CD81 are also candidates
for cell fusion molecules; however, defects
in multinucleation of osteoclasts and macro-
phages have not been identified by gene tar-
geting (6, 7).
Dendritic cell–specific transmembrane pro-
tein (DC-STAMP) is a seven-transmembrane
protein originally identified in dendritic cells
or IL-4–stimulated macrophages (8, 9). Re-
cently, it has been reported to induce differen-
tiation of osteoclasts (10). However, the role
of DC-STAMP in cell–cell fusion and in vivo
bone formation remains unknown. We gener-
ated DC-STAMP–deficient mice, demonstrat-
ing that multinucleation of osteoclasts and
macrophages is completely abrogated in 
 
DC-
STAMP
 
 
 
/
 
 
 
 mice.
 
RESULTS AND DISCUSSION
Identification and gene targeting 
of 
 
DC-STAMP
 
To identify molecules functioning in cell fusion,
we undertook subtractive screening between
multinuclear osteoclasts and mononuclear
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macrophages, both of which are derived from common pre-
cursor cells. Multinuclear osteoclasts were induced by mac-
rophage colony-stimulating factor (M-CSF) and receptor
activator of NF-
 
 
 
B ligand (RANKL); macrophages, which
do not fuse, were induced by M-CSF alone (11). The
screen identified DC-STAMP (clone SU166), also known
as IL-4–induced gene (9), which is specifically expressed in
osteoclasts among cells of the monocyte/macrophage lin-
eage (Fig. 1 A). Weak expression of DC-STAMP was de-
tected in activated dendritic cells stimulated with granulo-
cyte/M-CSF (GM-CSF) and RANKL (unpublished data),
consistent with the fact that DC-STAMP was also cloned
from a dendritic cell cDNA library (8). We identified two
isoforms of 
 
DC-STAMP
 
 expressed at equivalent levels in
osteoclasts: a full-length form (available from GenBank/
EMBL/DDBJ under accession no. AY517483) and a splice
variant lacking the third and fourth transmembrane domains
and designated 
 
DC-STAMP-splice
 
 (available from Gen-
Bank/EMBL/DDBJ under accession no. AY517484; Fig.
S1, available at http://www.jem.org/cgi/content/full/
jem.20050645/DC1).
GM-CSF is a potent inhibitor of osteoclastogenesis:
cells treated with GM-CSF differentiate into immature
dendritic cells that do not fuse even in the presence of
M-CSF and RANKL (12). Expression of DC-STAMP was
abolished in the presence of GM-CSF (Fig. 1 A), suggest-
ing that DC-STAMP regulates cell fusion. To determine
its function, we undertook gene targeting of 
 
DC-STAMP
 
(Fig. 1 B and Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20050645/DC1). The ATG start
codon of DC-STAMP is located in exon 2. The targeting
vector was constructed to insert an 
 
enhanced green fluorescent
protein 
 
(
 
EGFP
 
) sequence into exon 2 such that EGFP was
in frame with amino acid Leu
 
55
 
 of DC-STAMP. This mu-
tation resulted in deletion of the second through fifth
transmembrane domains, resulting in mutation of both the
full-length and splice variant form of DC-STAMP. Het-
erozygotes were mated, and DC-STAMP–nulls were gen-
erated at Mendelian ratios as determined at 4–8 wk of age
(
 
 
 
/
 
 
 
, 78 [23.3%]; 
 
 
 
/
 
 
 
, 179 [53.4%]; and 
 
 
 
/
 
 
 
, 78 [23.3%]).
Targeted disruption of both the full-length and splice vari-
ant forms of 
 
DC-STAMP
 
 was confirmed by RT-PCR
Figure 1. Identification and gene targeting of DC-STAMP. (A) Specific 
expression of DC-STAMP (arrow) in osteoclasts (M-CSF   RANKL) was 
determined among macrophages (M-CSF alone), immature dendritic cells 
(M-CSF   RANKL   GM-CSF), and osteoclasts derived from common 
precursor cells by Northern blot analysis. (B) The endogenous DC-STAMP 
locus (DC-STAMP gene), targeting vector, and targeted locus (mutant 
allele) are shown. Exons, represented by black boxes, are numbered. The 
ATG start codon is located in exon 2. The neomycin resistance gene (Neo) 
and EGFP-polyA sequence are indicated. The probe used for Southern 
hybridization is indicated (P). The EGFP-polyA sequence and Neo cassette 
were inserted into exon 2 to yield a construct encoding a DC-STAMP (1–55)–
EGFP chimeric protein. (C) RT-PCR analysis of the expression of DC-STAMP 
and the chimeric DC-STAMP-EGFP genes in osteoclasts and bones from 
mice of the indicated genotypes. (D) TRAP staining in tibias of 8-wk-old 
DC-STAMP /  or DC-STAMP /  mice (a) and the number of multinuclear 
TRAP-positive cells (b). Multinuclear osteoclast formation was abrogated 
in DC-STAMP /  mice. Values represent SD. 
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analysis using common primer sets to detect both forms
(Fig. 1 C).
 
Multinucleation is abrogated in 
 
DC-STAMP
 
 
 
/
 
 
 
 osteoclasts
 
Notably, no multinuclear osteoclasts were identified in bone
sections of 
 
DC-STAMP
 
 homozygotes (Fig. 1 D). To con-
firm these observations, we performed in vitro culture of os-
teoclasts with an osteoclast marker. Tartrate-resistant acid
phosphatase (TRAP)–positive multinuclear osteoclasts were
generated from mononuclear cells derived from wild-type
mice in the presence of M-CSF and RANKL, but multinu-
cleation was completely abrogated in osteoclasts derived
from 
 
DC-STAMP
 
 
 
/
 
 
 
 mouse mononuclear cells (Fig. 2
A). Interestingly, mononuclear TRAP-positive cells were
present in 
 
DC-STAMP
 
 
 
/
 
 
 
 mice as shown in Fig. 2 A, sug-
gesting that osteoclastogenesis occurs without cell fusion in
 
DC-STAMP
 
 
 
/
 
 
 
 osteoclasts. In fact, the total TRAP activity
of TRAP-positive cells derived from 
 
DC-STAMP
 
 
 
/
 
 
 
 mice
was higher than that seen in wild-type mice (Fig. 2 B).
RANK signals play an important role in osteoclast differ-
entiation, including multinucleation and bone resorption via
up-regulating NFATc1 expression (13–15). The expression
of osteoclast markers and transcription factors required for os-
teoclast differentiation, including RANK and NFATc1, was
induced by M-CSF and RANKL in 
 
DC-STAMP
 
 
 
/
 
 
 
 cells, as
well as in wild-type cells (Fig. 2 C and Fig. S3, available at
http://www.jem.org/cgi/content/full/jem.20050645/DC1).
Ruffled borders and actin rings, which are highly specific cy-
toskeletal features seen in osteoclasts, were formed in 
 
DC-
STAMP
 
 
 
/
 
 
 
 osteoclasts, in further support of the fact that
DC-STAMP is not involved in mononuclear osteoclast de-
velopment (Fig. 2 D and not depicted).
Multinuclear cell formation is dependent on cell density.
The total number of nuclei in cultures of osteoclasts was com-
parable between 
 
DC-STAMP
 
 
 
/
 
 
 
 and wild-type mice, indi-
cating that inhibition of multinucleation was not caused by re-
duced cell density in 
 
DC-STAMP
 
 
 
/
 
 
 
 cell cultures (Fig. 2 E).
Furthermore, the proportion of osteoclast precursor cells
(c-Fms
 
 
 
c-Kit
 
 
 
Mac1
 
low
 
) in 
 
DC-STAMP
 
 
 
/
 
 
 
 mice was equiva-
lent to that seen in wild-type mice (Fig. 2 F), indicating that
osteoclast differentiation from precursors to mononuclear osteo-
clasts was not affected. Osteoclasts derived from 
 
DC-STAMP
 
 
 
/
 
 
 
mice were mononuclear and exhibited bone-resorbing activity
(Fig. 2 G); however, the bone-resorbing area exhibited in cul-
tures of 
 
DC-STAMP
 
 
 
/
 
 
 
 osteoclasts was small compared with
wild-type cells (Fig. 2 G), even though the total number of
nuclei was equal (Fig. 2 E), suggesting that multinucleation
enhances the resorbing efficiency of osteoclasts.
Figure 2. Lack of multinucleation in DC-STAMP /  osteoclasts. 
(A) TRAP expression was induced, but multinucleation was completely 
abrogated in DC-STAMP /  osteoclasts. TRAP staining (a) and the number of 
multinuclear TRAP-positive cells (b) are shown. Values represent SD. Bar, 
50  m. (B) TRAP solution assay of macrophages (M-CSF alone) and osteo-
clasts (M-CSF   RANKL). (C) Expression of c-fos, NFATc1, or cathepsin K in 
macrophages (M-CSF alone) or osteoclasts (M-CSF   RANKL) derived from 
DC-STAMP / , DC-STAMP / , or DC-STAMP /  mice was analyzed by 
RT-PCR. NC, no template control. (D) Ruffled border formation was detected 
in osteoclasts of DC-STAMP /  tibial sections under electron microscopy. 
RB, ruffled border. (E) Total number of nuclei in cultured osteoclasts. Values 
represent SD. (F) The percent frequency of a population of osteoclast pre-
cursor cells (boxes, c-Fms c-Kit Mac-1low) is shown as the mean   SD. 
(G) Resorbing lacunae were visualized by toluidine blue O staining (a), and 
relative resorbing areas were scored (b). Values represent SD. 
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Bone mass is increased in 
 
DC-STAMP
 
 
 
/
 
 
 
 mice
 
Decreased bone resorption seen in 
 
DC-STAMP
 
 
 
/
 
 
 
 com-
pared with wild-type mice was observed as increased bone
mass (Fig. 3). Soft x-ray analysis showed an elevated ra-
dioopacity in 
 
DC-STAMP
 
 
 
/
 
 
 
 mice (Fig. 3 A). Bone mineral
density (BMD) and bone volume per tissue volume (BV/
TV) was increased in 
 
DC-STAMP /  mice compared with
wild-type mice (Fig. 3, B and C). Furthermore, trabecular
bone mass was increased in DC-STAMP /  mice (Fig. 3 D),
indicating that loss of osteoclast cell fusion leads to an osteo-
petrotic phenotype. However, because tooth eruption and
formation of the bone marrow cavity was normal in DC-
STAMP /  mice, such osteopetrosis was relatively mild
compared with mouse mutants exhibiting strong osteope-
trotic phenotypes such as c-Fos knockout or op/op mice
(2, 16). Collectively, our observations indicate that bone-
resorbing activity is stimulated by cell fusion and its disrup-
tion affects the bone as indicated by osteopetrosis.
DC-STAMP is indispensable for cell fusion of osteoclasts
To exclude the possibility that the lack of cell fusion seen in
DC-STAMP /  mice could be caused by reduced expres-
sion of other factors, we analyzed expression of factors
known to function in cell fusion (4–6, 17). Such factors,
which included macrophage fusion receptor, E-cadherin,
meltrin- , CD44, and CD47, were expressed similarly in
DC-STAMP /  as in wild-type mice (Fig. S4, available at
http://www.jem.org/cgi/content/full/jem.20050645/DC1).
Integrin  v 3 plays a role in osteoclast adhesion and differen-
tiation (18, 19); however, the expression level of adhesion
molecules was unchanged in DC-STAMP /  relative to
wild-type osteoclasts (Fig. S5, available at http://www.jem.
org/cgi/content/full/jem.20050645/DC1).
To confirm that DC-STAMP is indispensable for osteo-
clast fusion, DC-STAMP was transduced into osteoclast pro-
genitor cells isolated from DC-STAMP /  mice using retro-
virus infection. This treatment effectively rescued osteoclast
cell fusion, indicating that DC-STAMP is required for os-
teoclast cell fusion (Fig. 4 A). Transduction of the splice
variant failed to induce cell fusion (Fig. 4 A). Currently, the
function of that construct is unclear.
DC-STAMP is a member of the seven-transmembrane
receptor family, and it may function as a chemokine recep-
tor; if that were the case, loss of cell fusion could be caused
by reduced cell contact caused by impaired cell migration.
To test this hypothesis, cells were cultured at high density
to induce migration-independent cell contact (18). Dra-
matic multinucleation was induced in osteoclasts derived
from wild-type mice, whereas no fusion occurred in DC-
STAMP /  osteoclasts, indicating that fusion is inhibited
even under cell-to-cell contact conditions (Fig. 4 B). Osteo-
blasts play a key role in osteoclast differentiation through cy-
tokines such as M-CSF and RANKL or cell-adhesion sig-
nals. In the case of DC-STAMP /  mice, the fusion signal
was not rescued in vivo or by cocultivation with osteoblasts
(Fig. 4 B). High doses of M-CSF have been reported to re-
store the osteoclastogenesis defect seen in integrin  3
 /  mice
or DAP12 /  mice in vitro (19, 20). Long-term culture or
high doses of M-CSF and RANKL did not induce cell fu-
sion, and multinucleation was still completely abrogated in
DC-STAMP /  osteoclasts (unpublished data).
Next, we asked how cell fusion is mediated through
DC-STAMP. Supernatants of wild-type osteoclast cultures
did not induce fusion in DC-STAMP /  osteoclasts, and su-
pernatants from DC-STAMP /  osteoclast cultures did not
inhibit multinucleation of wild-type osteoclasts (unpublished
data). Thus, cell fusion induced by DC-STAMP is not me-
diated via unknown soluble factors but by direct interaction
between DC-STAMP and a putative ligand expressed by
mononuclear osteoclasts. In that case, a homogeneous popu-
lation of osteoclast precursors likely serves as founder and fu-
sion-competent cells, similar to myoblasts. To address this
possibility, mixed cultures of osteoclast precursors isolated
from DC-STAMP /  and wild-type mice were created. In-
terestingly, multinuclear EGFP-expressing cells were in-
duced in these cultures in the presence of M-CSF plus
RANKL, suggesting that fusion between EGFP-positive
DC-STAMP /  cells and wild-type osteoclast precursor cells
was induced (Fig. 4 C). These data indicate two possibilities:
Figure 3. Increased bone mass in DC-STAMP /  mice. (A) Soft x-ray 
analysis. Elevated radioopacity was observed in DC-STAMP /  mice. (B) In-
creased BMD (mg/cm2) was detected in DC-STAMP /  mice (closed circles) 
compared with DC-STAMP /  mice (open circles) by the dual energy x-ray 
absorptiometry method measured in 20 longitudinal divisions of femurs 
from 8-wk-old female mice. (C) Bone morphometric analysis of tibia 
from 8-wk-old mice. The percent BV/TV was elevated in DC-STAMP /  
mice compared with wild-type mice (*, P   0.01). Values represent SD. 
(D) Increased numbers of trabeculae were observed in tibial sections of 
DC-STAMP /  mice by toluidine blue staining.JEM VOL. 202, August 1, 2005 349
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(a) a putative DC-STAMP ligand is expressed on osteoclasts,
or (b) expression of DC-STAMP is required only in fusion
founder cells and not in both founder and fusion-competent
cells. Heterogeneous EGFP expression in DC-STAMP–
EGFP knock-in cells during the course of osteoclast differ-
entiation (unpublished data) supports the latter possibility.
Thus, DC-STAMP might be involved in cell–cell interac-
tions in a receptor–ligand fashion.
Multinucleation is abrogated in DC-STAMP /  FBGCs
DC-STAMP may also be required to form other monocyte-
derived multinucleated giant cells, such as FBGCs. FBGCs
are induced by fusion of macrophages in response to foreign
bodies at the site of implantation (3). Interestingly, multinu-
cleation of FBGCs induced by implantation of foreign bod-
ies was also inhibited in DC-STAMP /  mice (Fig. 5 A).
FBGCs are formed in vitro from monocyte progenitors by
stimulation with cytokines such as IL-3 and IL-4 (21).
FBGC formation by combined IL-3 and IL-4 treatment was
abrogated in DC-STAMP /  cells (Fig. 5 B), indicating that
DC-STAMP is universally required for monocyte lineage
cell fusion. The evidence that DC-STAMP is overexpressed
in giant cell tumors, which are primary bone neoplasm-con-
taining, multinucleated osteoclast-like giant cells compared
with normal tissues (22), supports involvement of DC-
STAMP in pathological giant cell formation.
DC-STAMP was originally isolated from dendritic cells,
which do not fuse (8). We are now evaluating the function
of dendritic cells in DC-STAMP–deficient mice. Dendritic
cells differentiate from the same precursors as osteoclasts, and
stimulation of dendritic cell differentiation inhibits osteoclast
formation, including multinucleation (12). These findings
suggest that expression of a putative DC-STAMP ligand
might require osteoclast induction stimuli, or that intracellu-
lar events after DC-STAMP binding to such a ligand in os-
teoclasts play an important role in cell fusion. DC-STAMP
has been reported to be expressed on the surface of os-
teoclasts (10) and in the endoplasmic reticulum of DC-
STAMP–transduced dendritic cells or 293 cells (23). Phago-
somes fuse with the endoplasmic reticulum in dendritic cells
(24), suggesting that DC-STAMP may function in such a
cytoplasmic membrane fusion. Thus, differences in DC-
STAMP localization may explain differences of multinucle-
ation between osteoclasts/FBGCs and dendritic cells, both
of which express DC-STAMP. Identification of a DC-
STAMP ligand should resolve these questions.
Figure 4. Rescue of cell fusion in DC-STAMP /  osteoclasts. (A) Osteo-
clast precursors from DC-STAMP /  mice were transduced by retrovirus 
expressing full-length (full) or a splice variant form (splice) of DC-STAMP 
(a). The indicated form of DC-STAMP expressed via retroviral infection was 
detected in DC-STAMP /  osteoclasts by RT-PCR analysis (b). NC, no tem-
plate control. Bar, 50  m. (B) No multinuclear TRAP-positive cells were 
induced in DC-STAMP /  cells by high density culture (a) or cocultivation 
with osteoblasts (b). Bar, 50  m. (C) 2   104 cells/well of M-CSF–dependent 
osteoclast precursors from DC-STAMP /  and DC-STAMP /  mice were 
mixed and cultured in the presence of M-CSF and RANKL for 4 d in 
96-well culture plates. Cells were stained by rabbit anti-EGFP antibody 
followed by Alexa 488 (EGFP)–conjugated anti–rabbit IgG antibody with 
rhodamine-conjugated phalloidin for F-actin staining and TOTO3 for 
nuclear staining. Note the formation of EGFP-positive multinuclear cells.
*, EGFP-negative multinuclear cells; **, EGFP-positive multinuclear cells.DC-STAMP: A FUSION PROTEIN FOR OSTEOCLASTS AND FBGCS | Yagi et al. 350
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Targeted disruption of the DC-STAMP gene. The EGFP-polyA gene
was inserted into the BamHI site in exon 2 in frame with the juxtamem-
brane region of the first transmembrane domain of DC-STAMP. Exon 2
was replaced by EGFP-polyA and the PGK-Neo gene to yield a targeting
vector. The Ethics Review Committee for Animal Experimentation of
Keio University approved the experimental protocol.
Analysis of skeletal morphology. BMD (mg/cm2) and bone radio-
graphs of 8-wk-old DC-STAMP /  and DC-STAMP /  littermates were
measured by the dual energy x-ray absorptiometry method using a DCS-
600R (Aloka Co. Ltd.) and a soft x-ray apparatus (Softex Co. Ltd.), respec-
tively. BV/TV was determined by bone morphometric analysis.
Cell culture. Macrophages and osteoclasts were induced in the presence
of M-CSF and RANKL or by cocultivation of osteoclast precursor cells
with osteoblasts as previously described (11). Osteoclastogenesis was evalu-
ated by either TRAP staining or a TRAP solution assay as previously de-
scribed (18). For the pit formation assay, retroviral transduction, and FBGC
formation assay, unfractionated BM cells were pretreated with 50 ng/ml
M-CSF for 2 d, and M-CSF–dependent cells were harvested and used as
progenitor cells. The resorbing lacunae were visualized by toluidine blue O
staining (15), and the relative resorbing area was scored under a microscope
(IX70; Olympus). Preparation of retrovirus was as previously described
(12). For FBGC induction, M-CSF–dependent progenitors were cultured
in the presence of 100 ng/ml IL-3 (Wako) and 100 ng/ml IL-4 (R&D Sys-
tems) for 4 d, and May-Gruenwald Giemsa staining was performed.
Immunohistochemical staining. Cells cultured in dishes were fixed with
4% paraformaldehyde/PBS and stained with the anti-EGFP antibody (Mo
Bio Laboratories, Inc.), followed by Alexa 488–conjugated anti–rabbit IgG
antibody (Invitrogen) with TOTO3 (Invitrogen) for nuclear staining, and
F-actin was stained by rhodamine-conjugated phalloidin (Invitrogen). For
electron microscopic analysis, ultrathin sections were stained with uranyl acetate
and lead citrate and observed with an electron microscope (H-7500; Hitachi).
In vivo FBGC formation. Ivalon surgical product (M-PACT, 10   10  
0.5 mm; Eudora) was implanted s.c. in DC-STAMP /  and DC-STAMP / 
mice. After 12 d, implants were harvested, and histological analyses were
performed by hematoxylin and eosin staining. Multinuclear cells containing
more than three nuclei that adhered to implants were scored as FBGC in
five independent fields per section isolated from four independent im-
planted mice.
RT-PCR analysis. Total RNA was extracted from cultured macrophages
or osteoclasts using an RNeasy mini kit (QIAGEN). First-strand cDNA was
prepared, and PCR was performed as previously described (18). Primer sets
used to detect various molecules are as previously described (12, 15, 18).
Online supplemental material. Figs. S1 and S2 describe the amino acid
sequence information of DC-STAMP and the generation of DC-STAMP/
EGFP knock-in mice, respectively. Fig. S3 shows the expression of tran-
scription factors, Fig. S4 depicts candidate molecules for cell fusion, and Fig.
S5 shows adhesion molecules in DC-STAMP / ,  / , or  /  osteoclasts.
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20050645/DC1.
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